Device
Pacemaker implant
Pacemaker implant is a medical device with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Other(2)
Detailed Status
Recruiting2
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed120%
recruiting240%
unknown240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingnot_applicable
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
NCT03303612
recruitingnot_applicable
Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy
NCT06474819
completednot_applicable
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
NCT06026683
unknownnot_applicable
Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)
NCT03860090
unknownnot_applicable
Evaluation of a New Cardiac Pacemaker
NCT01700244
Clinical Trials (5)
Showing 5 of 5 trials
NCT03303612Not Applicable
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
NCT06474819Not Applicable
Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy
NCT06026683Not Applicable
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
NCT03860090Not Applicable
Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)
NCT01700244Not Applicable
Evaluation of a New Cardiac Pacemaker
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5